152 related articles for article (PubMed ID: 28385366)
1. Prognostic factors in head and neck mucosal malignant melanoma.
Çomoğlu Ş; Polat B; Çelik M; Şahin B; Enver N; Keleş MN; Sarı ŞÖ
Auris Nasus Larynx; 2018 Feb; 45(1):135-142. PubMed ID: 28385366
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247
[TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
J Invest Dermatol; 2012 Apr; 132(4):1247-52. PubMed ID: 22297638
[TBL] [Abstract][Full Text] [Related]
4. Sarcoma-like tumor of head and neck skin.
Nonaka D; Bishop PW
Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristic and prognostic analyses of 117 cases of head and neck mucosal melanoma].
Yin GF; Guo W; Chen XH; Liu ZY; Huang ZG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep; 53(9):668-674. PubMed ID: 30293258
[No Abstract] [Full Text] [Related]
6. Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators.
Kerr EH; Hameed O; Lewis JS; Bartolucci AA; Wang D; Said-Al-Naief N
Int J Surg Pathol; 2012 Feb; 20(1):37-46. PubMed ID: 21862490
[TBL] [Abstract][Full Text] [Related]
7. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of S100/CD31 and S100/podoplanin double immunostaining in mucosal malignant melanoma of the head and neck.
Wermker K; Brauckmann T; Klein M; Haßfeld S; Schulze HJ; Hallermann C
Head Neck; 2015 Sep; 37(9):1368-74. PubMed ID: 24817089
[TBL] [Abstract][Full Text] [Related]
9. Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis.
Ruskin O; Sanelli A; Herschtal A; Webb A; Dixon B; Pohl M; Donahoe S; Spillane J; Henderson MA; Gyorki DE
Head Neck; 2016 Sep; 38(9):1373-9. PubMed ID: 27014970
[TBL] [Abstract][Full Text] [Related]
10. Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.
Hale CS; Qian M; Ma MW; Scanlon P; Berman RS; Shapiro RL; Pavlick AC; Shao Y; Polsky D; Osman I; Darvishian F
Am J Surg Pathol; 2013 Jun; 37(6):882-9. PubMed ID: 23629443
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
[TBL] [Abstract][Full Text] [Related]
12. Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions.
Rees MJ; Liao H; Spillane J; Speakman D; McCormack C; Donahoe S; Pohl M; Webb A; Gyorki D; Henderson MA
Eur J Surg Oncol; 2016 Sep; 42(9):1359-66. PubMed ID: 26899940
[TBL] [Abstract][Full Text] [Related]
13. Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients.
Andersson AP; Gottlieb J; Drzewiecki KT; Hou-Jensen K; Sondergaard K
Cancer; 1992 Mar; 69(5):1153-6. PubMed ID: 1739914
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis.
Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Insa A; Fortea JM
Melanoma Res; 2005 Jun; 15(3):169-77. PubMed ID: 15917698
[TBL] [Abstract][Full Text] [Related]
15. Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck.
Thierauf J; Veit JA; Affolter A; Bergmann C; Grünow J; Laban S; Lennerz JK; Grünmüller L; Mauch C; Plinkert PK; Hess J; Hoffmann TK
Melanoma Res; 2015 Dec; 25(6):503-9. PubMed ID: 26352784
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
[TBL] [Abstract][Full Text] [Related]
17. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
Tetzlaff MT; Curry JL; Ivan D; Wang WL; Torres-Cabala CA; Bassett RL; Valencia KM; McLemore MS; Ross MI; Prieto VG
Mod Pathol; 2013 Sep; 26(9):1153-60. PubMed ID: 23558574
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
19. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of head and neck mucosal melanoma in 66 patients vs 226 patients with cutaneous melanoma: A survival analysis.
Luna-Ortiz K; Villavicencio-Valencia V; Martinez Said H
Clin Otolaryngol; 2018 Apr; 43(2):691-696. PubMed ID: 28986955
[No Abstract] [Full Text] [Related]
[Next] [New Search]